Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$1.2 - $2.19 $1,374 - $2,507
-1,145 Reduced 9.74%
10,615 $14,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $2,681 - $5,790
1,645 Added 16.26%
11,760 $19,000
Q3 2022

Nov 09, 2022

SELL
$0.73 - $3.74 $6,945 - $35,586
-9,515 Reduced 48.47%
10,115 $31,000
Q2 2022

Aug 11, 2022

BUY
$2.2 - $4.2 $43,186 - $82,446
19,630 New
19,630 $46,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.